Birgitta Mörk

555 total citations
10 papers, 470 citations indexed

About

Birgitta Mörk is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Birgitta Mörk has authored 10 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Birgitta Mörk's work include Drug Transport and Resistance Mechanisms (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Birgitta Mörk is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Birgitta Mörk collaborates with scholars based in Sweden. Birgitta Mörk's co-authors include M. Axelson, Jan Sjövall, Rolf Lewensohn, Kristina Viktorsson, Dali Zong, Petra Hååg, Lovisa Lundholm, Gregory T. Everson, Magnus Axelson and Ewa Ellis and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and FEBS Letters.

In The Last Decade

Birgitta Mörk

10 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgitta Mörk Sweden	10	246	231	168	81	50	10	470
Richard Martin United States	8	172 0.7×	282 1.2×	93 0.6×	53 0.7×	46 0.9×	9	577
Wakashi Kitayama Japan	11	71 0.3×	187 0.8×	68 0.4×	88 1.1×	91 1.8×	18	547
An–Qiang Sun United States	14	501 2.0×	253 1.1×	407 2.4×	149 1.8×	17 0.3×	21	777
Michael W. Lago United States	10	93 0.4×	209 0.9×	58 0.3×	32 0.4×	30 0.6×	13	538
Naoaki Murao Japan	15	161 0.7×	205 0.9×	61 0.4×	30 0.4×	15 0.3×	26	624
Giancarlo Lunazzi Italy	11	180 0.7×	139 0.6×	61 0.4×	50 0.6×	15 0.3×	11	354
Alessia Francesca Mozzi Italy	9	119 0.5×	184 0.8×	134 0.8×	47 0.6×	11 0.2×	12	476
Masahiko Sunaga Japan	13	123 0.5×	233 1.0×	43 0.3×	79 1.0×	82 1.6×	25	491
Mona L. Coetzee United States	13	69 0.3×	215 0.9×	164 1.0×	119 1.5×	81 1.6×	30	533

Countries citing papers authored by Birgitta Mörk

Since Specialization

Citations

This map shows the geographic impact of Birgitta Mörk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitta Mörk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitta Mörk more than expected).

Fields of papers citing papers by Birgitta Mörk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitta Mörk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitta Mörk. The network helps show where Birgitta Mörk may publish in the future.

Co-authorship network of co-authors of Birgitta Mörk

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitta Mörk. A scholar is included among the top collaborators of Birgitta Mörk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitta Mörk. Birgitta Mörk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zong, Dali, Petra Hååg, Metka Novak, et al.. (2015). DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 15(1). 628–628. 27 indexed citations

Zong, Dali, et al.. (2014). Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer. Cell Death and Disease. 5(3). e1111–e1111. 36 indexed citations

Lundholm, Lovisa, Petra Hååg, Dali Zong, et al.. (2013). Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death and Disease. 4(1). e478–e478. 90 indexed citations

Ståhl, Sara, Christopher M. Adams, Johan Lengqvist, et al.. (2009). Proteomics and Pathway Analysis Identifies JNK Signaling as Critical for High Linear Energy Transfer Radiation-induced Apoptosis in Non-small Lung Cancer Cells. Molecular & Cellular Proteomics. 8(5). 1117–1129. 20 indexed citations

Axelson, M., Ewa Ellis, Birgitta Mörk, et al.. (2000). Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology. 31(6). 1305–1312. 74 indexed citations

Axelson, Magnus, Birgitta Mörk, & Jan Sjövall. (1991). Ethanol has an acute effect on bile acid biosynthesis in man. FEBS Letters. 281(1-2). 155–159. 38 indexed citations

Axelson, M., Birgitta Mörk, & Gregory T. Everson. (1991). Bile acid synthesis in cultured human hepatoblastoma cells.. Journal of Biological Chemistry. 266(27). 17770–17777. 46 indexed citations

Axelson, M., et al.. (1989). Concentrations of cholestenoic acids in plasma from patients with liver disease.. Journal of Lipid Research. 30(12). 1877–1882. 27 indexed citations

Axelson, M., et al.. (1989). Concentrations of cholestenoic acids in plasma from patients with reduced intestinal reabsorption of bile acids.. Journal of Lipid Research. 30(12). 1883–1887. 15 indexed citations

10.

Axelson, M., Birgitta Mörk, & Jan Sjövall. (1988). Occurrence of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid as normal constituents in human blood.. Journal of Lipid Research. 29(5). 629–641. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact